Tumor cells can evade immune attack by expressing programmed death-ligand-1 (PD-L1), which binds to its corresponding receptor on immune cells, programmed cell death protein-1 (PD-1), thereby inhibiting immune cell activity. The gene discussed is PDCD1; the disease is neoplasm.